Robert Fox
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent (NCT04333290) | Robert Fox | 2024-07-24 |
| Safety of Bryostatin in Patients With MS (NCT06190912) | Robert Fox | 2024-06-26 |
Track Robert Fox automatically
Every clearance here is in the API, with alerts when new ones post.